Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Menstrual Cycle Hormones and Eating Behavior (FL-84)

1. december 2017 opdateret af: USDA, Western Human Nutrition Research Center

Effect of Menstrual Cycle Hormone Changes on Eating Behavior and Nutrient Metabolism

The purpose of this study is to determine if the phase of the menstrual cycle (opposed versus unopposed estrogen phase) affects eating behavior, including types of foods preferred, wanting/desire for specific foods, and perception of hunger.

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

This is an observational study to investigate the effect of endogenous estrogen (E2) and progesterone (P4) levels on eating behavior and energy-yielding nutrient metabolism. Eating behavior will be assessed during a complete menstrual cycle during the first month of the study. Participants will track the follicular and luteal phases of their menstrual cycle using urinary leuteinizing hormone (LH) kits, they will record information about their food intake, eating behaviors, and appetite in their home environments, and they will complete two laboratory test days: one test day scheduled during their follicular phase, and one test day scheduled during their luteal phase.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

24

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • California
      • Davis, California, Forenede Stater, 95616
        • USDA, ARS, Western Human Nutrition Research Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 35 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Healthy, premenopausal women.

Beskrivelse

Inclusion Criteria:

  • Body Mass Index between 20-30 Kg/m2
  • regular menstrual cycles
  • sedentary lifestyle (physical activity not more than 30 minutes per day three times a week)

Exclusion Criteria:

  • Fasting blood sugar greater than 110 mg/dL
  • Systolic Blood Pressure greater than 140 mmHg
  • Diastolic Blood Pressure greater than 90 mmHg
  • Fasting triglycerides greater than 120 mg/dL
  • Documented or self-reported chronic disorders such as arthritis, or other inflammatory diseases
  • Women who are Post-menopausal or Peri-menopausal
  • Pre-menopausal women who are pregnant, uni/multiparous, taking oral contraceptives, or who have menstrual cycles lasting less than 20 days or greater than 45 days, polycystic ovary syndrome (PCOS), amenorrhea, eumenorrhoea, or polymenorrhoea.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Eating behavior
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Eating behavior, including types of foods preferred, wanting/desire for specific foods, and perception of hunger will be measured using four questionnaires; Eating inventory: to assess dietary restraint, Stanford Brief Physical Activity Questionnaire, Food craving questionnaire, Eating behavior and attitudes questionnaire
At follicular (day 11) and luteal (day 26) phase of menstrual cycle

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Insulin sensitivity
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
To determine if the phase of the menstrual cycle affects insulin sensitivity, we will measure plasma insulin, glucose and non-esterified fatty acids (NEFA).
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Serum lipid profile changes
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Blood samples will be analyzed for lipids and lipoproteins, including apoproteins A1, B, C-II, C-III, and E.
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Urinary c-peptide
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
The level of urinary C-peptide and creatinine will be measured in a 24-hour urine collection.
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Estradiol
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Estradiol measured in serum in relation to appetite variables
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
progesterone
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Progesterone measured in serum in relation to appetite variables
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Dehydroepiandrosterone (DHEA)
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Dehydroepiandrosterone measured in serum in relation to appetite variables
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Sex Hormone Binding Globulin (SHBG)
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
SHBG measured in serum in relation to appetite variables
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Endocannabinoid profile
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Endocannabinoid profile measured in serum to assess appetite
At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Leptin
Tidsramme: At follicular (day 11) and luteal (day 26) phase of menstrual cycle
Leptin measured in serum to assess appetite
At follicular (day 11) and luteal (day 26) phase of menstrual cycle

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Nancy Keim, PhD, USDA, ARS, Western Human Nutrition Research Center

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. marts 2011

Primær færdiggørelse (Faktiske)

1. december 2012

Studieafslutning (Faktiske)

1. december 2012

Datoer for studieregistrering

Først indsendt

26. juli 2011

Først indsendt, der opfyldte QC-kriterier

29. juli 2011

Først opslået (Skøn)

2. august 2011

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. december 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

1. december 2017

Sidst verificeret

1. december 2017

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • WHNRC 221594-1

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner